糖组学结合人工智能:聚糖分析助力识别血清阳性与血清阴性类风湿关节炎患者
结果显示,糖组学与RA标志物联合可将血清阳性RA的区分准确率从83.3%提升至92.5%,且免疫分析完全无法识别血清阴性RA患者,而聚糖分析可正确识别其中43.8%。
要点
- 糖组学联合RA标志物可提高血清阳性RA识别准确率至92.5%。
- 免疫分析无法识别血清阴性RA患者,聚糖分析可识别43.8%。
- 样本类型、分析格式和捕获抗体取向是聚糖分析的关键参数。
核心结论
- 糖组学分析结合人工智能可提高血清阳性RA的识别准确率,并有助于识别免疫分析无法检出的血清阴性RA患者。
主要发现
- 关键RA标志物区分健康人与血清阳性RA患者的准确率为83.3%。
- RA标志物联合聚糖分析将区分准确率提高至92.5%。
- 免疫分析完全无法识别血清阴性RA患者,而聚糖分析正确识别了43.8%的血清阴性RA患者。
关键数值与推荐
- 血清阳性RA区分准确率:RA标志物83.3%,联合聚糖分析92.5%。
- 血清阴性RA识别率:免疫分析0%,聚糖分析43.8%。
临床怎么用
- 对于免疫分析标志物阴性的疑似RA患者,可考虑补充聚糖分析以提高检出率。
- 进行聚糖分析时需关注样本类型、分析格式及捕获抗体取向等关键参数。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
In this study, one hundred serum samples from healthy people and patients with rheumatoid arthritis (RA) were analyzed. Standard immunoassays for detection of 10 different RA markers and analysis of glycan markers on antibodies in 10 different assay formats with several lectins were applied for each serum sample. A dataset containing 2000 data points was data mined using artificial neural networks (ANN). We identified key RA markers, which can discriminate between healthy people and seropositive RA patients (serum containing autoantibodies) with accuracy of 83.3%. Combination of RA markers with glycan analysis provided much better discrimination accuracy of 92.5%. Immunoassays completely failed to identify seronegative RA patients (serum not containing autoantibodies), while glycan analysis correctly identified 43.8% of these patients. Further, we revealed other critical parameters for successful glycan analysis such as type of a sample, format of analysis and orientation of captured antibodies for glycan analysis.
引用
- Chocholova E, Bertok T, Jane E, et al. Glycomics meets artificial intelligence - Potential of glycan analysis for identification of seropositive and seronegative rheumatoid arthritis patients revealed. Clin Chim Acta. 2018. PMID: 29486148. doi:10.1016/j.cca.2018.02.031
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。